Retrospective analysis on protocol violation of anti-tumor drug clinical trials from the perspective of ethical review
1Medical Ethics Committee, Peking University Cancer Hospital & Institute/Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
2Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute/Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
3Department of Hepato Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute/Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
收起